These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 20695297)

  • 1. [Mitochondrial recessive ataxia syndrome (MIRAS) and valproate toxicity].
    Hakonen AH; Isohanni P; Rantamäki M; Kälviäinen R; Nordin A; Uusimaa J; Paetau A; Udd B; Pihko H; Wartiovaara A
    Duodecim; 2010; 126(13):1552-9. PubMed ID: 20695297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do carriers of POLG mutation W748S have disease manifestations?
    Rantamäki M; Luoma P; Virta JJ; Rinne JO; Paetau A; Suomalainen A; Udd B
    Clin Genet; 2007 Dec; 72(6):532-7. PubMed ID: 17894835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult-onset ataxia and polyneuropathy caused by mitochondrial 8993T-->C mutation.
    Rantamäki MT; Soini HK; Finnilä SM; Majamaa K; Udd B
    Ann Neurol; 2005 Aug; 58(2):337-40. PubMed ID: 16049925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute liver failure after valproate exposure in patients with POLG1 mutations and the prognosis after liver transplantation.
    Hynynen J; Komulainen T; Tukiainen E; Nordin A; Arola J; Kälviäinen R; Jutila L; Röyttä M; Hinttala R; Majamaa K; Mäkisalo H; Uusimaa J
    Liver Transpl; 2014 Nov; 20(11):1402-12. PubMed ID: 25065347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [NARP syndrome--a less known mitochondrial disease].
    Kuusisto H; Simola KO; Keränen T
    Duodecim; 2003; 119(16):1563-6. PubMed ID: 14535029
    [No Abstract]   [Full Text] [Related]  

  • 7. Brain pseudoatrophy and mental regression on valproate and a mitochondrial DNA mutation.
    Galimberti CA; Diegoli M; Sartori I; Uggetti C; Brega A; Tartara A; Arbustini E
    Neurology; 2006 Nov; 67(9):1715-7. PubMed ID: 17101920
    [No Abstract]   [Full Text] [Related]  

  • 8. Clonally expanded mitochondrial DNA mutations in epileptic individuals with mutated DNA polymerase gamma.
    Zsurka G; Baron M; Stewart JD; Kornblum C; Bös M; Sassen R; Taylor RW; Elger CE; Chinnery PF; Kunz WS
    J Neuropathol Exp Neurol; 2008 Sep; 67(9):857-66. PubMed ID: 18716558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome and status epilepticus.
    Uusimaa J; Hinttala R; Rantala H; Päivärinta M; Herva R; Röyttä M; Soini H; Moilanen JS; Remes AM; Hassinen IE; Majamaa K
    Epilepsia; 2008 Jun; 49(6):1038-45. PubMed ID: 18294203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Valproate treatment during pregnancy: description of four cases with foetal valproate syndrome].
    Sabers A; Larsen K; Blichfeldt S; Sahlholdt L; Rasmussen JO
    Ugeskr Laeger; 2009 Jan; 171(4):221-5. PubMed ID: 19174036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperammonemic encephalopathy associated with valproate acid].
    Osuna MT; Burcet J; Ramió L; Ustrell X; Silva Y; Molins A
    Neurologia; 2003; 18(6):347-50. PubMed ID: 12838456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthotopic liver transplantation with poor neurologic outcome in valproate-associated liver failure: a need for critical risk-benefit appraisal in the use of valproate.
    Thomson MA; Lynch S; Strong R; Shepherd RW; Marsh W
    Transplant Proc; 2000 Feb; 32(1):200-3. PubMed ID: 10701024
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutation of DNAJC19, a human homologue of yeast inner mitochondrial membrane co-chaperones, causes DCMA syndrome, a novel autosomal recessive Barth syndrome-like condition.
    Davey KM; Parboosingh JS; McLeod DR; Chan A; Casey R; Ferreira P; Snyder FF; Bridge PJ; Bernier FP
    J Med Genet; 2006 May; 43(5):385-93. PubMed ID: 16055927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hyperammonemic coma with chronic valproic acid therapy.
    Cuturic M; Abramson RK
    Ann Pharmacother; 2005 Dec; 39(12):2119-23. PubMed ID: 16288075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Valproate-associated carnitine deficiency and malignant cerebral edema in the absence of hepatic failure.
    Triggs WJ; Gilmore RL; Millington DS; Cibula J; Bunch TS; Harman E
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):353-6. PubMed ID: 9314085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Encephalopathies caused by valproate].
    Göbel R; Görtzen A; Bräunig P
    Fortschr Neurol Psychiatr; 1999 Jan; 67(1):7-11. PubMed ID: 10065384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial diseases represent a risk factor for valproate-induced fulminant liver failure.
    Krähenbühl S; Brandner S; Kleinle S; Liechti S; Straumann D
    Liver; 2000 Jul; 20(4):346-8. PubMed ID: 10959815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Parkinsonism induced by sodium valproate].
    del Real Francia MA; Sanz Martínez J; Vaamonde Gamo J; Gudín Rodríguez-Magariños M; Ibáñez Alonso R; Riñón V
    Neurologia; 1995 Nov; 10(9):381-3. PubMed ID: 8554795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute liver necrosis caused by valproate].
    Zäh W; Rengeling M; Rühl G; Hackenberg K
    Dtsch Med Wochenschr; 1985 Jun; 110(24):956-9. PubMed ID: 3922731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of valproate-induced hyperammonemic encephalopathy: look beyond the liver.
    Alqahtani S; Federico P; Myers RP
    CMAJ; 2007 Sep; 177(6):568-9. PubMed ID: 17846437
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.